Staphylococcal infections

Laboratory Diagnosis of Bacterial Infections

Volumn , Issue , 2001, Pages 229-256

  Cimolai, Nevio ^a   Espersen, Frank ^b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651418683     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (149)

1. Sheagren JN. Staphylococcus aureus: The persistent pathogen (part I). N Engl J Med 1984; 310: 1368-1373.
2. Sheagren JN. Staphylococcus aureus: the persistent pathogen (part II). N Engl J Med 1984; 310: 1437-1442.
3. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-532.
4. Espersen F, Frimodt-Moller N, Thamdrup Rosdahl V, Jessen O. Staphylococcus aureus bacteraemia in children below the age of one year. Acta Paediatr Scand 1989; 78:56-61.
5. Frimodt-Moller N, Espersen F, Skinhoj P. Thamdrup Rosdahl V. Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin Microbiol Infect 1997; 3:297-305.
6. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffman CA, Yu VL. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993; 94:313-328.
7. Cookson B. Aspects of the epidemiology of MRSA in Europe. J Chemother 1995; 7:93-98.
8. Corso A, Santos Sanches I, Aires de Sousa M, Rossi A, de Lencastre H. Spread of a methicillin-resistant and multiresistant epidemic clone of Staphylococcus aureus in Argentina. Microb Drug Resist 1998; 4:277-288.
9. Anonymous. Update: Staphylococcus aureus with reduced susceptibility to vancomycin — United States, 1997. MMWR 1997; 46:813-815.
10. Perl TM. The threat of vancomycin resistance. Am J Med 1999; 106:S26-S37.
11. Wallmark GI, Anemark I, Telander B. Staphylococcus saprophyticus: a frequent cause of urinary tract infections among female outpatients. J Infect Dis 1978; 138:791-797.
12. Kloos WE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994;7:117-140.
13. Nafziger DA, Wenzel RP. Coagulase-negative staphylococci: epidemiology, evaluation, and therapy. Infect Dis Clin North Am 1989; 3:915-929.
14. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10:505-520.
15. Noble WC. Skin bacteriology and the role of Staphylococcus aureus in infection. Br J Dermatol 1998; 139: S9-S12.
16. Ladhani S, Joannou CL, Lochrie DP, Evans RW, Poston SM. Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 1999; 12:224-242.
17. Crane JK. Preformed bacterial toxins. Clin Lab Med 1999; 19:583-599.
18. Wieneke AA, Roberts D, Gilbert RJ. Staphylococcal food poisoning in the United Kingdom, 1969-1990. Epidemiol Infect 1993; 110:519-531.
19. Chesney PJ, Bergdoll MS, Davis JP, Vergeront JM. The disease spectrum, epidemiology, and etiology of toxic- shock syndrome. Ann Rev Microbiol 1984; 38:315-338.
20. Stevens DL. The toxic shock syndromes. Infect Dis Clin North Am 1996; 10:727-746.
21. Broome CV. Epidemiology of toxic shock syndrome in the United States. Rev Infect Dis 1989; 11: S14-S21.
22. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988; 1:281-299.
23. Edmiston CE, Schmitt DD, Seabrook GR. Coagulase-negative staphylococcal infection in vascular surgery: epidemiology and pathogenesis. Infect Control Hosp Epidemiol 1989; 10:111-117.
24. Magee JT, Burnett IA, Hindmarch JM, Spencer RC. Micrococcus and Stomatococcus spp. from human infections. J Hosp Infect 1990; 16:67-73.
25. Stackebrandt E. Koch C, Gvozdiak O, Schumann P. Taxonomic dissection of the genus Micrococcus: Kocuria gen. nov., Nesterenkonia gen. nov., Kytococcus gen. nov., Dermacoccus gen. nov., and Micrococcus Cohn 1872 gen. emend. Int J Syst Bacteriol 1995; 45:682-692.
26. Ascher DP, Zbick C, White C, Fischer GW. Infections due to Stomatococcus mucilaginosus: ten cases and review. Rev Infect Dis 1991; 13:1048-1052.
27. Kaufhold A, Reinert RR, Kem W. Bacteremia caused by Stomatococcus mucilaginosus: report of seven cases and review of the literature. Infection 1992; 20:213-220.
28. Gruson D, Hilbert G, Pigneux A, Vargas F, Guisset O, Texier J, Boiron JM, Reiffers J, Gbikpi-Benissan G, Cardinaud JP. Severe infection caused by Stomatococcus mucilaginosus in a neutropenic patient: case report and review of the literature. Hematol Cell Ther 1998; 40:167-169.
29. Goldman M, Chaudhary UB, Greist A, Fausel CA. Central nervous system infections due to Stomatococcus mucilaginosus in immunocompromised hosts. Clin Infect Dis 1998; 27:1241-1246.
30. Bosley GS, Whitney AM, Pruckler JM, Moss CW, Daneshvar M, Sih T, Talkington DF. Characterization of ear fluid isolates of Alloiococcus otitidis from patients with recurrent otitis media. J Clin Microbiol 1995; 33:2876-2880.
31. Perl TM, Golub JE. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage. Ann Pharmacother 1998; 32:S7-S16.
32. Perl TM, Roy MC. Postoperative wound infections: risk factors and role of Staphyloccus aureus nasal carriage. J Chemother 1995; 7:S29-S35.
33. Casewell MW. The nose: an underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect 1998; 40:S3-S11.
34. Kluytmans J. Reduction of surgical site infections in major surgery by elimination of nasal carriage of Staphylococcus aureus. J Hosp Infect 1998; 40:S25-S29.
35. Espersen F. Identifying the patient risk for Staphylococcus aureus bloodstream infections. J Chemother 1995; 7:S11-S17.
36. Jensen AG, Wachmann CH, Poulsen KB, Espersen F, Scheibel J, Skinhoj P, Frimodt-MollerN. Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med 1999; 159:1437-1444.
37. Bradley SF. Methicillin-resistant Staphylococcus aureus in nursing homes: epidemiology, prevention and management. Drugs Aging 1997; 10:185-198.
38. Bradley SF. Methicillin-resistant Staphylococcus aureus: long-term care concerns. Am J Med 1999; 106: S2-S10.
39. Espersen F, Rosdahl VT, Frimodt-Miller N, Skinhoj P. Epidemiology of Staphylococcus aureus bacteremia in Denmark. J Chemother 1994; 6:219-225.
40. Doebbling BN. The epidemiology of methicillin-resistant Staphylococcus aureus colonisation and infection. J Chemother 1995; 7:99-103.
41. Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol 1998; 19:552-559.
42. Herwaldt LA. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 1999; 106: S11-S18.
43. Casewell MW. New threats to the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 1995; 30:S465-S471.
44. Kluytmans J, van Leeuwen W, Goessens W, Hollis R, Messer S, Herwadlt L, Braining H, Heck M, Rost J, van Leeuwen N, van Belkum A, Verbrugh H. Food-initiated outbreak of methicillin-resistant Staphylococcus aureus analyzed by pheno- and genotyping. J Clin Microbiol 1995; 33:1121-1128.
45. Hubner J, Kropec A. Cross infections due to coagulase-negative staphylococci in high-risk patients. Zentralbl Bakteriol 1995;283:169-174.
46. Bialkowska-Hobrzanska H, Jaskot D, Hammerberg O. Evaluation of restriction endonuclease fingerprinting of chromosomal DNA and plasmid profile analysis for characterization of multiresistant coagulase-negative staphylococci in bacteremic neonates. J Clin Microbiol 1990; 28:269-275.
47. Thylefors J.D., Harbarth S, Pittet D. Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect Cont Hosp Epidemiol 1998; 19: 581-589.
48. Gilligan PH, Gage PA, Welch DF, Muszynski MJ, Wait ICR. Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol 1987; 25:1258-1261.
49. Skurray RA, Rouch DA, Lyon BR, Gillespie MT, Tennent JM, Byrne ME, Messerotti LJ, May JW. Multiresistant Staphylococcus aureus: genetics and evolution of epidemic Australian strains. J Antimicro Chemother 1988; 21: S19-S39.
50. Albus A, Fournier JM, Wolz C, Boutonnier A, Ranke M, Hoiby N, Hochkeppel H, Doring G. Staphylococcus aureus capsular types and antibody response to lung infection in patients with cystic fibrosis. J Clin Microbiol 1988; 26:2505-2509.
51. Foster TJ, McDevitt D. Surface-associated proteins of Staphylococcus aureus: their possible roles in virulence. FEMS Microbiol Lett 1994; 118: 199-205.
52. Parsonnet J. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev Infect Dis 1989; 11: S263-S269.
53. Kass EH, Parsonnet J. On the pathogenesis of toxic shock syndrome. Rev Infect Dis 1987; 9: S482-S489.
54. Johnson HM, Torres BA, Soos JM. Superantigens: structure and relevance to human disease. Proc Soc Exp Biol Med 1996;212: 99-109.
55. Gemmell CG. Staphylococcal scalded skin syndrome. J Med Microbiol 1995; 43:318-327.
56. Krakauer T. Immune response to staphylococcal superantigens. Immunol Res 1999; 20:163-173.
57. Peterson PK, Wilkinson BJ, Kim Y, Schmeling D, Douglas SD, Quie P. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest 1978; 61:597-609.
58. Cunningham R, Cockayne A, Humphreys H. Clinical and molecular aspects of the pathogenesis of Staphylococcus aureus bone and joint infections. J Med Microbiol 1996; 44:157-164.
59. Villavicencio RT, Wall MJ Jr. The pathogenesis of Staphylococcus aureus in the trauma patient and potential future therapies. Am J Surg 1996; 172:291-296.
60. Wadstrom T. Molecular aspects on pathogenesis of wound and foreign body infections due to staphylococci. Zentralbl Bakteriol Mikrobiol Hyg [A] 1987; 266: 191-211.
61. Hancock IC. Encapsulation of coagulase-negative staphylococci. Zentralbl Bakteriol 1989; 272:11-18.
62. Fleer A, Timmerman CP, Besnier JM, Pascuual A, Verhoef J. Surface proteins of coagulase-negative staphylococci: their role in adherence to biomaterials and in opsonization. J Biomater Appl 1990; 5:154-165.
63. Von Eiff C, Heilmann C, Herrmann M, Peters G. Basic aspects of the pathogenesis of staphylococcal polymer- associated infections. Infection 1999; 27:S7-S10.
64. Goldmann DA, Pier GB. Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev 1993;6:176-192.
65. St Geme JW, Harris MC. Coagulase-negative staphylococcal infection in the neonate. Clin Perinatol 1991; 18:281-302.
66. Wheat J, Kohler RB, Garten M, White A. Commercially available (ENDO-STAPH) assay for teichoic acid antibodies: evaluation in patients with serious Staphylococcus aureus infections and in controls. Arch Intern Med 1984; 144:261-264.
67. Wise KA, Tosolini FA. Detection of teichoic acid antibodies in Staphylococcus aureus infections. Pathology 1992; 24:102-108.
68. Kunstmann G, Schroder E, Hasbach H, Pulverer G. Immune response to toxic-shock syndrome toxin-1 (TSST-1) and to staphylococcal enterotoxins A, B, and C in Staphylococcus aureus infections. Zentralbl Bakteriol 1989; 271:486-492.
69. Tenover FC, Arbeit R, Archer G, Biddle J, Byrne S, Goering R, Hancock G, Hebert GA, Hill B, Hollis R. Jarvis WR, Kreiswirth B, Eisner W, Maslow J, McDougal LK, Miller JM, Mulligan M, Pfaller MA. Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus. J Clin Microbiol 1994; 32:407-415.
70. Traub WH, Bauer D, Leonhard B. Immunobology of methicillin-resistant Staphylococcus aureus: immune response of rabbits and patients to systemic infection. Chemotherapy 1996; 42; 118-132.
71. Fattom A, Li X, Cho YH, Bums A, Hawwari A, Shepheerd SE, Coughlin R Winston S, Naso R. Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides. Vaccine 1995; 13:1288-1293.
72. Hauser C, Wuethrich B, Matter L, Wilhelm JA, Schopfer K. Immune response to Staphylococcus aureus in atopic dermatitis. Dermatologica 1985; 170:114-120.
73. Plaunt MR, Patrick CC. Identification of the innate human immune response to surface-exposed proteins of coagulase-negative staphylococci. J Clin Microbiol 1991; 29:857-861.
74. Henke PK, Bergamijni TM, Garrison JR, Brittian KR, Peyton JC, Lam TM. Staphylococcus epidermidis graft infection is associated with locally suppressed major histocompatibility complex class II and elevated MAC-1 expression. Arch Surg 1997; 132:894-902.
75. Gray ED, Peters G, Verstegen M, Regelmann WE. Effect of extracellular slime substance from Staphylococcus epidermidis to the human cellular immune response. Lancet 1984; i: 365-367.
76. Bayston R, Rodgers J. Role of serological tests in the diagnosis of immune complex disease in infection of ventriculoatrial shunts for hydrocephalus. Eur J Clin Microbiol Infect Dis 1994; 13:417-420.
77. Espersen F, Wilkinson BJ, Wheat LJ, White A, Bayer AS, Hopper DC. Antibody response to Staphylococcus epidermidis'. comparison of ultrasonic extract and cell wall antigens for serological diagnosis of coagulase- negative staphylococcal endocarditis. Serodiagn Immunother 1987; 1:367-378.
78. Baird RM, Lee WH. Media used in the detection and enumeration of Staphylococcus aureus. Int J Food Microbiol 1995; 26:15-24.
79. Lally RT, Ederer MN, Woolfrey BF. Evaluation of mannitol salt agar with oxacillin as a a screening medium for methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1985; 22:501-504.
80. Fleurette J, Bes M, Brun Y, Freney J, Forey F, Coulet M, Reverdy ME, Etienne J. Clinical isolates of Staphylococcus lugdenensis and S. schleiferi: bacteriological characteristics and susceptibility to antimicrobial agents. Res Microbiol 1989; 140:107-118.
81. Wilkerson M. McAllister S, Miller JM, Heiter BJ, Bourbeau PP. Comparison of five agglutination tests for identification of Staphylococcus aureus. J Clin Microbiol 1997; 35:148-151.
82. Personne P, Bes M, Lina G, Vandenesch F, Brun Y, Etienne J. Comparative performance of six agglutination kits assessed by using typical and atypical strains of Staphylococcus aureus. J Clin Microbiol 1997; 35:1138-1140.
83. Cooke RP, Jenkins CT. Comparison of commercial slide agglutination kits with a tube coagulase for the rapid identification of Staphylococcus aureus from blood culture. J Clin Pathol 1997; 50:164-166.
84. Vandenesch F, Bes M, Lebeau C. Greenland T, Brun Y, Etienne J. Coagulase-negative Staphylococcus aureus. Lancet 1993; 342:995-996.
85. Madison BM, Baselski VS. Rapid identification of Staphylococcus aureus in blood cultures by thermonuclease testing. J Clin Microbiol 1983; 18:722-724.
86. Megson GM, Law D, Ganguli LA. Problems of thermonuclease detection for identifying Staphylococcus aureus in blood culture broths. J Clin Pathol 1991; 44: 772-774.
87. Skulnick M, Simor AE, Patel MP, Simpson HE, O’Quinn KJ, Low DE, Phillips AM, Small GW. Evaluation of three methods for the rapid identification of Staphylococcus aureus in blood cultures. Diagn Microbiol Infect Dis 1994; 19:5-8.
88. Skov RL, Palleson LV, Poulsen RL, Espersen F. Evaluation of a new 3-h hybridization method for detecting the mecA gene in Staphylococcus aureus and comparison with existing genotypic and phenotypic susceptibility testing methods. J Antimicrob Chcmother 1999; 43:467-475.
89. Rasooly L, Rose NR, Shah DB, Rasoolly A. In vitro assay of Staphylococcus aureus enterotoxin A activity in food. Appl Environ Microbiol 1997; 63:2361-2365.
90. Mehrotra M, Wang G, Johnson WM. Multiplex PCR for detection of genes for Staphylococcus aureus entero- toxins, exfoliative toxins, toxic shock syndrome toxin I, and methicillin resistance. J Clin Microbiol 2000; 38:1032-1035.
91. Schumacher-Perdreau F, Akatova A, Pulverer G. Detection of staphylococcal enterotoxin B and toxic shock syndrome toxin: PCR versus conventional methods. Zentralbl Bakteriol 1995; 282:367-371.
92. Roder BL, Eriksen NH, Nielsen LP, Slotsbjerg T, Rosdahl VT, Espersen F. No difference in enterotoxin production among Staphylococcus aureus isolated from blood compared with strains isolated from healthy carriers. J Med Microbiol 1995; 42:43-47.
93. Kellogg JA, Hanna MD, Nelsen SJ, Sprenkle LS, Thomas ML, Young KS. Predictive values of species identifications from the Vitek Gram-Positive Identification Card using clinical isolates of coagulase-negative staphylococci. Am J Clin Pathol 1996; 106:374-377.
94. Ieven M, Verhoeven J, Pattyn SR, Goossens H. Rapid and economical method for species identification of clinically significant coagulase-negative staphylococci. J Clin Microbiol 1995; 33:1060-1063.
95. Janda WM, Ristow K, Novak D. Evaluation of RapiDEC Staph for identification of Staphylococcus aureus, Staphylococcus epidermidis, and Staphylococcus saprophyticus. J Clin Microbiol 1994; 32:2056-2059.
96. Perl TM, Rhomberg PR, Bale MJ, Fuchs PC, Jones RN, Koontz FP, Pfaller MA. Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus species. Diagn Microbiol infect Dis 1994; 18:151-155.
97. Grant CE, Sewell DL, Pfaller M, Bumgardner RV, Williams JA. Evaluation of two commercial systems for identification of coagulase-negative staphylococci to species level. Diagn Microbiol Infect Dis 1994; 18: 1-5.
98. Bannerman TL, Kleeman KT, Kloos WE. Evaluation of the Vitek Systems Gram-Positive identification card for species identification of coagulase-negative staphylococci. J Clin Microbiol 1993; 31: 1322-1325.
99. Rhoden DL, Miller JM. Four-year prospective study of STAPH-IDENT system and conventional method for reference identification of Staphylococcus, Stomatococcus, and Micrococcus spp. J Clin Microbiol 1995; 33: 96-98.
100. Gribaldo S, Cookson B, Saunders N, Marples R, Stanley J. Rapid identification by specific PCR of coagulase- negative staphylococcal species important in hospital infection. J Med Microbiol 1997; 46: 45-53.
101. Rhoden DL, Hancock GA, Miller JM. Numerical approach to reference identification of Staphylococcus, Stomatococcus, and Micrococcus spp. J Clin Microbiol 1993; 31: 490-493.
102. Faller A, Schleifer KH. Modified oxidase and benzidine tests for separation of staphylococci from micrococci. J Clin Microbiol 1981; 13: 1031-1035.
103. Geary C, Stevens M. Rapid lysostaphin test to differentiate Staphylococcus and Micrococcus species. J Clin Microbiol 1986; 23: 1044-1045.
104. Poutrel B, Caffin JP. Lysostaphin disk test for routine presumptive identification of staphylococci. J Clin Microbiol 1981; 13: 1023-1025.
105. van der Zee A, Verbakel H, van Zon JC, Frenay I. van Belkum A, Peeters M, Buiting A, Bergmans A. Molecular genotyping of Staphylococcus aureus strains: comparison of repetitive element sequence-based PCR with various typing methods and isolation of a novel epidemicity marker. J Clin Microbiol 1999; 37: 342-349.
106. Tambic A, Power EGM, Talsania H, Anthony RM, French GL. Analysis of an outbreak of non-phage-typeable methicillin-resistant Staphylococcus aureus by using a randomly amplified polymorphic DNA assay. J Clin Microbiol 1997; 35: 3092-3097.
107. Hookey JV, Richardson JF, Cookson BD. Molecular typing of Staphylococcus aureus based on PCR restriction fragment length polymorphism and DNA sequence analysis of the coagulase gene. J Clin Microbiol 1998; 36: 1083-1089.
108. Cuny C, Witte W. Typing of Staphylococcus aureus by PCR for DNA sequences flanked by transposon Tn916 target region and ribosomal binding site. J Clin Microbiol 1996; 34: 1502-1505.
109. Olmos A, Camarena JJ, Nogueira JM, Navarro JC, Risen J, Sanchez R. Application of an optimized and highly discriminatory method based on arbitrarily primed PCR for epidemiologic analysis of methicillin-resistant Staphylococcus aureus nosocomial infections. J Clin Microbiol 1998; 36: 1128-1134.
110. del Vecchio VG, Petroziello JM, Gress MJ, McCleskey FK, Melcher GP, Crouch HK, Lupski JR. Molecular genotyping of methicillin-resistant Staphylococcus aureus via fluorophore-enhanced repetitive-sequence PCR. J Clin Microbiol 1995; 33: 2141-2144.
111. Enright MC, Day NPJ, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptibie clones of Staphylococcus aureus. J Clin Microbiol 2000; 38:1008-1015.
112. van Belkum A, van Leeuwen W, Kaufmann ME, Cookson B, Forey F, Etienne J, Goering R, Tenover F, Steward C, O’Brien F, Grubb W. Tassios P. Legakis N, Morvan A, El Solh N, de Ryck R, Struelens M, Salmen- linna S, Vuopio-Varkila J, Kooistra M, Talens A, Witte W, Verbrugh H. Assessment of resolution and intercenter reproducibility of results of genotyping Staphylococcus aureus by pulsed-field gel electrophoresis of Smal macrorestriction fragments: a multicenter study. J Clin Microbiol 1998; 36: 1653-1659.
113. Kluytmans J, Berg H, Steegh P, Vandenesch F, Etienne J, van Belkum A. Outbreak of Staphylococcus schleiferi wound infections: strain characterization by randomly amplified polymorphic DNA analysis, PCR ribo-typing, conventional ribotyping. and pulsed-field gel electrophoresis. J Clin Microbiol 1998; 36: 2214-2219.
114. Carlos CC, Ringertz S, Rylander M, Huovincn P, Faxelius G. Nosocomial Staphylococcus epidermidis septicaemia among very low birth weight neonates in the an intensive care unit. J Hosp Infect 1991; 19: 201-207.
115. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Wayne, PA: NCCLS, 1997.
116. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Wayne, PA:NCCLS, 1997.
117. Thomsberry C. The development of antimicrobial resistance in staphylococci. J Antimicrob Chemother 1988; 21: S9-S17.
118. Petersson AC, Eliasson I, Kamme C, Miomer H. Evaluation of four qualitative methods for detection of beta- lactamase production in Staphylococcus and Micrococcus species. Eur J Clin Microbiol Infect Dis 1989; 8: 962-967.
119. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997; 10: 781-791.
120. Petersson AC, Miomer H, Kamme C. Identification of mec/f-related oxacillin resistance in staphylococci by the E test and the broth microdilution method. J Antimicrob Chemother 1996; 37: 445-456.
121. Michel M, Gutmann L. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet 1997; 349: 1901-1906.
122. McDougal LK, Thomsberry C. The role of beta-lactamase in staphylococcal resistance to penicillinase- resistant penicillins and cephalosporins. I Clin Microbiol 1986; 23: 832-839.
123. Montanari MP, Massidda O, Mingoia M, Varaldo PE. Borderline susceptibility to methicillin in Staphylococcus aureus: a new mechanism of resistance? Microb Drug Resist 1996; 2: 257-260.
124. Zaher A, Al-Thawadi S, Cimolai N. Beta-lactamase negative, methicillin-resistant Staphylococcus aureus lacking the mecA gene determinant. J Antimicrob Chemother 1997; 39: 108-109.
125. van Griethuysen A, Pouw M, van Leeuwen N, Heck M, Willemse P, Buiting A, Kluytmans J. Rapid slide latex aggutination test for detection of methicillin resistance in Staphylococcus aureus. J Clin Microbiol 1999; 37: 2789-2792.
126. van Leeuwen WB, van Pelt C, Luijendijk A, Verbrugh HA, Goessens WH. Rapid detection of methicillin resistance in Staphylococcus aureus isolates by the MRSA-screen latex agglutination test. J Clin Microbiol 1999;37: 3029-3030.
127. Ishida K, Guze PA, Kalmanson GM, Albrandt K, Guze LB. Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains. Antimicrob Agents Chemother 1982; 21: 688-690.
128. Goessens WH. Basic mechanisms of bacterial tolerance of antimicrobial agents. Eur J Clin Microbiol Infect Dis 1993; 12: S9-S12.
129. Voom GP, Thompson J, Goessens WH, Schmal-Bauer WC, Breeders PH, Michel MF. In vitro developemnt and stability of tolerance to cloxacilin and vancomycin in Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994; 13: 741-746.
130. Sherris JC. Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrob Agents Chemother 1986; 30: 633-637.
131. Ramos RL, Teixeira LA, Ormonde LR, Siqueira PL, Santos MS, Marangoni D, Figueiredo AM. Emergence of mupirocin resistance in multircsistant Staphylococcus aureus clinical isolates belonging to Brazilian epidemic clone III::B:A. J Med Microbiol 1999; 48: 303-307.
132. Carbon C. Costs of treating infections caused by methicillin-resistant staphylococci and voncomycin-resistant enterococci. J Antimicrob Chemo 1999; 44: S31-S36.
133. Lacey RW, Kruczenyk SC. Epidemiology of antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 1986; 18: S207-S214.
134. Ryffel C, Tesch W, Birch-Machin I, Reynolds PE, Barberis-Maino L. Kayser FH, Berger-Bachi B. Sequence comparison of mecA genes isolated from methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Gene 1990; 94: 137-138.
135. Suzuki E, Hiramatsu K, Yokota T. Survey of methicilin-resistant clinical strains of coagulase-negative staphylococci for mecA gene distribution. Antimicrob Agents Chemother 1992; 36: 429-434.
136. Cimolai N, Trombley C, Zaher A. Oxacillin susceptibility of coagulase-negative staphylococci: role for mecA genotyping and E-test susceptibility testing. Int J Antimicrob Agents 1997; 8: 121-125.
137. Predari SC, Ligozzi M, Fontana R. Genotypic identification of methicillin-resistant coagulase-negative staphylococci by polymerase chain reaction. Antimicrob Agents Chemother 1991; 35: 2568-2573.
138. Cimolai N. Ciprofloxacin and multiresistant staphylococci. Lancet 1997; 349: 1030.
139. Ramotar K, Bobrowska M, Jessamine P, Toye B. Detection of methicillin resistance in coagulase-negative staphylococci initially reported as methicillin susceptible using automated methods. Diagn Microbiol Infect Dis 1998;30: 267-273.
140. Rochette A, Chomarat M, de Montclos M. Sensitivity to antibiotics of 64 strains of Stomatococcus mucilagi- nosus isolated in human clinical cases. Pathol Biol 1988; 36: 394-397.
141. Marshall SA, Wilke WW, Pfaller MA, Jones RN. Staphylococcus aureus and coagulase-negative staphylococci from blood stream infections: frequency of occurrence, antimicrobial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program. Diagn Microbiol Infect Dis 1998; 30: 205-214.
142. Hussain Z, Stoakes L, Massey V, Diagre D, Fitzgerald V, El Sayed S, Lannigan R. Correlation of oxacillin MIC with mecA gene carriage in coagulase-negative staphylococci. J Clin Microbiol 2000; 38: 752-754.
143. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987; 316: 927-931.
144. Jenssen WD, Thakker-Varia S, Dubin DT, Weinstein MP. Prevalence of macrolides-lincosamides- streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob Agents Chemother 1987; 31: 883-888.
145. von Eiff C, Herrmann M, Peters G. Antimicrobial susceptibilities of Stomatococcus mucilaginosus and of Micrococcus spp. Antimicrob Agents Chemother 1995; 39: 268-270.
146. Pinsky RL, Piscitelli V, Patterson JE. Endocarditis caused by relatively penicillin-resistant Stomatococcus mucilaginosus. J Clin Microbiol 1989; 27: 215-216.
147. Ayliffe GA. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1997; 24: S74-S79.
148. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: ninth information supplement, vol. 19, no. 1. NCCLS document M100-S9. Wayne, PA, USA:NCCLS.
149. Noskin GA, Siddiqui F, Stosor V, Hacek D, Peterson LR. In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci. Antimicrob Agents Chemother 1999; 43: 2059-2062.